← back to search

Emiel A. M. Janssen

Griffith University · AU
Area of research
Cancer Research · Artificial Intelligence
Research interest
Research interests include Breast Cancer Treatment Studies, AI in cancer detection, Cervical Cancer and HPV Research, and Endometrial and Cervical Cancer Treatments.
h-index
29
citations
3,129
works
94
NIH funding
primary concept
Medicine
email

Recent publications

Digital image analysis and machine learning-assisted prediction of neoadjuvant chemotherapy response in triple-negative breast cancer
Breast Cancer Research 2024cited by 34position: middledoi
Image‐based multiplex immune profiling of cancer tissues: translational implications. A report of the International Immuno‐oncology Biomarker Working Group on Breast Cancer
The Journal of Pathology 2024cited by 16position: middledoi
Pitfalls in machine learning‐based assessment of tumor‐infiltrating lymphocytes in breast cancer: A report of the International Immuno‐Oncology Biomarker Working Group on Breast Cancer
The Journal of Pathology 2023cited by 49position: middledoi
Spatial analyses of immune cell infiltration in cancer: current methods and future directions: A report of the International Immuno‐Oncology Biomarker Working Group on Breast Cancer
The Journal of Pathology 2023cited by 49position: middledoi
Predicting Neoadjuvant Treatment Response in Triple-Negative Breast Cancer Using Machine Learning
Diagnostics 2023cited by 12position: middledoi
Estimating diagnostic uncertainty in artificial intelligence assisted pathology using conformal prediction
Nature Communications 2022cited by 103position: middledoi
A spatial attention guided deep learning system for prediction of pathological complete response using breast cancer histopathology images
Bioinformatics 2022cited by 44position: middledoi
A Case Series Exploration of Multi-Regional Expression Heterogeneity in Triple-Negative Breast Cancer Patients
International Journal of Molecular Sciences 2022cited by 10position: middledoi
Crown-Like Structures in Breast Adipose Tissue: Early Evidence and Current Issues in Breast Cancer
Cancers 2021cited by 48position: middledoi
Protein Conformational Changes in Breast Cancer Sera Using Infrared Spectroscopic Analysis
Cancers 2020cited by 62position: middledoi
Combined HER3-EGFR score in triple-negative breast cancer provides prognostic and predictive significance superior to individual biomarkers
Scientific Reports 2020cited by 56position: middledoi
Prognostic Role of Androgen Receptor in Triple Negative Breast Cancer: A Multi-Institutional Study
Cancers 2019cited by 75position: middledoi
Serum concentrations of active tamoxifen metabolites predict long-term survival in adjuvantly treated breast cancer patients
Breast Cancer Research 2017cited by 79position: middledoi
Amplified centrosomes and mitotic index display poor concordance between patient tumors and cultured cancer cells
Scientific Reports 2017cited by 27position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

Ritu Aneja · University of Alabama at Birmingham7 papers (2017–2024)Shristi Bhattarai · University of Alabama at Birmingham5 papers (2020–2024)Jun Kong · State Grid Corporation of China (China)4 papers (2022–2024)Mohammed A. Aleskandarany · Nottingham University Hospitals NHS Trust3 papers (2017–2022)Emad A. Rakha · Indiana University School of Medicine3 papers (2017–2022)Hongxiao Li · Tianjin University3 papers (2022–2023)Geetanjali Saini · University of Alabama at Birmingham2 papers (2023–2024)Karuna Mittal · Children's Healthcare of Atlanta2 papers (2017–2022) · 2 papers (2017–2020)Angela Ogden · University of Nottingham2 papers (2017–2020) · 2 papers (2022–2023) · 2 papers (2023–2024)Uma Krishnamurti · Yale New Haven Hospital2 papers (2020–2020)Timothy L. Lash · Emory Healthcare2 papers (2017–2021)Ian O. Ellis · University of Nottingham2 papers (2017–2020)Keerthi Gogineni · Emory University2 papers (2021–2022)Kristín Jónsdóttir · University of Oslo2 papers (2017–2020)Andrew R. Green · Rivers State University2 papers (2020–2022)Grethe I.G. Alnæs · Oslo University Hospital1 papers (2017–2017) · 1 papers (2024–2024)